Jenburkt Pharma launches COVID-19 drug at Rs 39 per tablet in India
Share Via Email
Published: 25th July 2020 02:29 PM |
Last Updated: 25th July 2020 02:30 PM
Drug firm Jenburkt Pharmaceuticals on Friday said it has launched antiviral drug #Favipiravir under the brand name 'Favivent' for the treatment of mild to moderate #COVID19 symptoms at a price of Rs 39 per tablet.